Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
This study not only provides real-world cost-effectiveness findings that complement evidence from trial- or model-based CEAs but also summarizes up-to-date cost-effectiveness evidence, both of which are of importance for clinical decision-making regarding treatment selections and the formulation of healthcare reimbursement policies in real-world practice
GLP-1 receptor agonists reduce appetite and body weight
A frequent guest-speaker, Dr
These outcomes made dual therapy attractive for patients with obesity and type 2 diabetes who failed to reach targets on monotherapy
:format(webp)/article/fV2krNQ2md1Y1FiwQCsf1/original/029505700_1568437249-Tren-Memutihkan-Kulit-dengan-Glutathione-Amankah-By-Asiandelight-Shutterstock.jpg)
US$ 20.61
US$ 26.05
US$ 21.22
